Table 2.
Generic and disease-specific quality of life and symptom severity according to treatment allocation
| Additional catheter-directed thrombolysis (n=90) | Standard treatment only (n=99) | Mean difference | p Value* | ||
|---|---|---|---|---|---|
| 24 months | |||||
| Generic QOL | EQ-5D | 0.80 (0.746 to 0.849) | 0.84 (0.807 to 0.875) | 0.04 (−0.01 to 0.17) | 0.705 |
| Disease-specific QOL | VEINES-QOL | 50.1 (47.9 to 52.3) | 49.9 (48.0 to 51.8) | 0.2 (−2.8 to 3.0) | 0.595 |
| VEINES-Sym | 50.3 (48.0 to 52.5) | 49.8 (47.9 to 51.6) | 0.5 (−2.4 to 3.4) | 0.368 | |
| 6 months | |||||
| Generic QOL | EQ-5D | 0.82 (0.780 to 0.856) | 0.81 (0.777 to 0.852) | 0.01 (−0.05 to 0.06) | 0.893 |
| Disease-specific QOL | VEINES-QOL | 51.3 (49.2 to 53.4) | 48.9 (46.8 to 50.9) | 2.4 (−0.5 to 5.3) | 0.048 |
| VEINES-Sym | 51.7 (49.8 to 53.7) | 48.5 (46.4 to 50.6) | 3.2 (0.4 to 6.1) | 0.016 | |
Data are mean values (95% CI).
*Mann Whitney U test.
QOL, quality of life.